Nash Marc 4

What Happened

• Marc Nash, EVP, Operations, R&D & Service at Outset Medical (OM), reported two sales totaling 6,355 shares for aggregate proceeds of about $32,400. On 2026-01-20 he sold 5,375 shares at $5.12 ($27,520) and on 2026-01-21 he sold 980 shares at $4.98 ($4,880). These sales were sell-to-cover transactions to satisfy tax withholding on vested RSUs, not discretionary market trades.

Key Details

• Transaction dates and prices:
  • 2026-01-20: Sold 5,375 shares @ $5.12 = $27,520
  • 2026-01-21: Sold 980 shares @ $4.98 = $4,880
• Total shares sold: 6,355; total proceeds ≈ $32,400.
• Footnote: Sales were made to cover partial tax withholding on the vesting of 14,839 RSU shares granted June 10, 2025; characterized as "sell to cover" and not discretionary (footnote F1).
• Shares owned after the transactions: not disclosed in the Form 4.
• Filing: Form 4 filed on 2026-01-21 reporting the 2026-01-20/01-21 transactions—appears timely (no late filing indicated).
• No 10b5-1 trading plan or other trading arrangement was disclosed in the filing.

Context

• "Sell-to-cover" is a routine action when restricted stock units vest and taxes are due; the broker sells a portion of the vested shares to cover withholding. Such transactions are administrative and generally do not signal management's view of the company's prospects. Purchases or large, discretionary insider buys tend to be more informative about insider sentiment.